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Receptor-associated protein (RAP) has two high-afﬁnity binding sites for
the low-density lipoprotein receptor-related protein (LRP): consequences
for the chaperone functions of RAP
Jan K. JENSEN, Klavs DOLMER, Christine SCHAR and Peter G. W. GETTINS1
Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland, M/C 669, Chicago, IL 60607, U.S.A.
RAP (receptor-associated protein) is a three domain 38 kDa
ER (endoplasmic reticulum)-resident protein that is a chaperone
for the LRP (low-density lipoprotein receptor-related protein).
Whereas RAP is known to compete for binding of all known
LRP ligands, neither the location, the number of binding sites
on LRP, nor the domains of RAP involved in binding is known
with certainty. We have systematically examined the binding of
each of the three RAP domains (D1, D2 and D3) to tandem
and triple CRs (complement-like repeats) that span the principal
ligand-binding region, cluster II, of LRP. We found that D3
binds with low nanomolar afﬁnity to all (CR)2 species examined.
Addition of a third CR domain increases the afﬁnity for D3
slightly. A pH change from 7.4 to 5.5 gave only a 6-fold increase
in Kd for D3 at 37◦C, whereas temperature change from 22◦C
to 37◦C has a similar small effect on afﬁnity, raising questions
about the recently proposed D3-destabilization mechanism of
RAP release from LRP. Surprisingly, and in contrast to literature
suggestions, D1 and D2 also bind to most (CR)2 and (CR)3
constructs with nanomolar afﬁnity. Although this suggested that
there might be three high-afﬁnity binding sites in RAP for LRP,
studies with intact RAP showed that only two binding sites are
available in the intact chaperone. These ﬁndings suggest a new
model for RAP to function as a folding chaperone and also for
the involvement of YWTD domains in RAP release from LRP
in the Golgi.
Key words: chaperone, ligand release, low-density lipoprotein
receptor (LDLR), LDLR-associated protein (LRP), receptor-
associated protein (RAP), YWTD domain.
INTRODUCTION
Members of the LDLR (low-density lipoprotein receptor) family
are involved in binding and internalizing a wide range of
structurally unrelated proteins [1,2]. Binding of ligands occurs
to regions of the receptors that are built from clusters of non-
identical copies of the CR (complement-like repeat) domain,
whichisan∼40residuemodulethatderivesitsstructuralintegrity
from the presence of three disulﬁdes and a calcium co-ordination
site. Probably because of the presence of such a high density
of disulﬁdes in these ligand-binding clusters of LDLR family
members, a chaperone is necessary for efﬁcient folding of these
receptors. For VLDLR (very-LDLR), LRP (LDLR-associated
protein) and some other members of the family, though perhaps
notLDLRitself[3],thischaperoneisthe38 kDaER(endoplasmic
reticulum)-residentproteinRAP(receptor-associatedprotein)[4–
8], which consists of three roughly equal-sized domains [9,10]
and terminates with an HNEL ER retention sequence [11]. It
has been proposed that RAP serves two critical functions with
respect to these receptors, the ﬁrst to ensure correct folding of
their CR domains and the second to prevent premature tight
binding of other protein ligands to the CR clusters within the ER
[9,12].
Although anearly report onthe number and location of binding
sites within RAP for LRP suggested that there are two such sites
[13], later quantitative studies, which compared the binding of
the third RAP domain (D3) with that of intact RAP found
apparently similar afﬁnities for D3 and intact RAP, implying that
the other two RAP domains contributed little to binding [9]. This
conclusion was reinforced by a study that used ITC (isothermal
titration calorimetry) to examine the binding of the CR tandem
construct CR56 (where CRxy is the LRP fragment containing
domains CRx and CRy) from ligand binding cluster II of LRP to
RAP domains D1, D2 and D3 that found moderately high afﬁnity
(0.2 μM) for D3, but much weaker afﬁnity for D1 (3 μM) and
D2 (19 μM) [14]. Similarly, low afﬁnity was found in a study
that examined the binding of CR56 to RAP D1 [15]. However,
there are potential problems with these studies in that the CR56
constructwaseitherimmobilizedorfusedtoubiquitin,whichmay
account for none of the afﬁnities approaching those reported for
either D3 or RAP for intact LRP (1–5 nM) [9].
To provide more complete and less ambiguous data on the
binding of RAP to LRP, we have systematically examined
the binding of tandem and triple CR domain constructs that
cover the portion of cluster II of LRP to which protein ligands
are known to bind (CR3–CR9) to each of the three domains of
RAP on their own, as well as in the context of intact RAP. Our
results from the present study provide evidence for tight binding
sites on each of the three domains of RAP, only two of which
can be simultaneously engaged in intact RAP. Of signiﬁcance for
the functioning of RAP is that each of these high-afﬁnity binding
sites is in the low nanomolar range, making it likely that both are
engaged in vivo. In addition, whereas there is a pH-dependence
of the binding of D3, it seems to be of too small a magnitude to be
the principal mechanism of dissociation of RAP from folded LRP
as the latter progresses from the ER to the lower pH environment
Abbreviations used: CR, complement-like repeat; (CR)x LRP fragment containing x CR domains; CRxy, LRP fragment containing domains CRx and
CRy;C R xyz, LRP fragment containing domains CRx,C R y and CRz; D1, D2 and D3, ﬁrst, second and third domains of RAP; ER, endoplasmic reticulum;
GST, glutathione transferase; IPTG, isopropyl β-D-thiogalactoside; ITC, isothermal titration calorimetry; 2-ME, 2-mercaptoethanol; LA34, third and fourth CR
domains from the ligand-binding cluster of LDLR; (V)LDLR, (very-) low-density lipoprotein receptor; LRP, low-density lipoprotein receptor-related protein;
RAP, receptor-associated protein;TEV, tobacco etch virus.
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oftheGolgi.Furthermore,nosuchpH-dependenceisobservedfor
D1orD2.Thisalsohasimplicationsforbindinganddisplacement
of protein ligands other than RAP. Based on these ﬁndings, we
propose a new model for how RAP may both function to promote
correct folding of LRP and subsequently dissociate as the folded
LRP is transported from the ER to the Golgi, with concomitant
loweringofthepH.Thelatteralsohasimplicationsfortherelease
ofproteinligandsfromLRPsubsequenttotheirreceptor-mediated
internalization.
MATERIALS AND METHODS
Expression, puriﬁcation and refolding of CR constructs
All CR constructs (see Supplementary Table S1 at http://www.
BiochemJ.org/bj/421/bj4210273add.htm) were expressed in 2YT
[1.6% (w/v) tryptone, 1% (w/v) yeast extract and 0.5% (w/v)
NaCl] medium. CR34, CR56, CR78 and CR567 (where CRxyz
is the LRP fragment containing domains CRx,C R y and CRz)
were cloned in pGEX-2T, modiﬁed to contain a TEV (tobacco
etch virus) cleavage site, and expressed as GST (glutathione
transferase)-fusion proteins in BL21 cells. Cells were grown
to D600 =0.6–1.0 before induction with 1 mM IPTG (isopropyl
β-D-thiogalactoside), and the cells were harvested after 5–6 h
incubation at 37 ◦C. The GST-fusion proteins were puriﬁed from
cleared cell lysate by GSH–Sepharose chromatography, and the
GST-tag was removed by TEV cleavage during overnight dialysis
against 4 litres of 20 mM Tris/HCl, pH 8.0, 50 mM NaCl and
4 mMEDTA,containing14 mM2-ME(2-mercaptoethanol).GST
anduncleavedGST–CRfusionproteinswereremovedbypassage
through the GSH-column.
CR89, CR345, CR456 and CR678 were cloned in pQE-
30, modiﬁed to contain a GB1 fusion partner and a TEV
cleavage site, and CR45 was cloned in pQE-30, modiﬁed to
contain a NusA fusion partner and a TEV cleavage site. These
His6 (hexahistidine)-tagged fusion proteins were expressed in
SG13009 cells containing the plasmid pRARE. The CR fusion
proteins were puriﬁed from cell lysate by Ni
2+ or TALON
chromatography, and the fusion partner was removed by TEV
cleavage during overnight dialysis against PBS containing either
14 or 7 mM 2-ME.
Before refolding, all (CR)x (LRP fragment containing x CR
domains) species were further puriﬁed by Q-Sepharose HP
chromatography, using a gradient of 0–1000 mM NaCl in 20 mM
Tris/HCl, pH 8.0, and 6 M urea. The denatured (CR)x species
were diluted to 0.1 mg/ml with 50 mM Tris/HCl, pH 8.5, 50 mM
NaCl and 10 mM CaCl2, and refolded by dialysis against buffer
containing14 mM2-MEand8 mM2-hydroxyethyldisulﬁde.For
increased folding efﬁciency, all (CR)x species except CR78 were
thenmixedwiththechaperoneGST–RAPasaGST-fusionprotein
[GST-RAP(IAA)] at a 1:1.25 ratio (CR:RAP) [16]. After 24 h
at room temperature (22◦C) with N2 bubbling, the dialysis was
continued for 24 h at 4◦C without N2. Finally, the mixture was
dialysed against 2×4 litres of 20 mM Tris/HCl, pH 7.8, 50 mM
NaCl and 1 mM CaCl2 at 4◦C. The refolding mixture was loaded
on to GSH–Sepharose, and folded CR constructs, i.e. those
capable of binding to RAP and therefore retained on the column,
were eluted with 40 mM Tris/HCl, pH 8.0, 100 mM NaCl and
8 mM EDTA. Folded (CR)x species were further puriﬁed by
Q-Sepharose HP chromatography (50–1000 mM NaCl in 20 mM
Tris/HCl, pH 8.0, and 0.1 mM CaCl2). If additional puriﬁcation
was needed, calcium was removed by EDTA and the (CR)x
species was passed through a Superdex 75 size-exclusion column
equilibrated in 20 mM Tris/HCl, pH 7.8, 150 mM NaCl and
4 mM EDTA.
As a quality control between each step of puriﬁcation, samples
wereanalysedbyreducingandnon-reducingSDS/PAGEandnon-
denaturing PAGE. The presence of a single band on SDS/PAGE
with a reduction in mobility under reducing conditions indicated
homogeneous samples, with formed disulﬁde bridges. A single
band on non-denaturing PAGE indicated the presence of a
single folding product. The ﬁnal products were judged to be more
than 95% pure by SDS/PAGE.
Expression and puriﬁcation of RAP
RAP cDNA, cloned in pGEX-2T, was a gift from Dr
Dudley Strickland (University of Maryland School of Medicine,
Baltimore, MA,U.S.A.).GST–RAP was expressedinBL21cells,
induced with 1 mM IPTG at a D600 =0.6–1.0, and harvested
after 5 h incubation at 25 ◦C. GST–RAP was puriﬁed by GSH–
Sepharosechromatography.GST–RAPthatwastobeusedforCR
refolding was then dialysed overnight against 4 litres of 20 mM
Tris/HCl, pH 8.0, 50 mM NaCl and 4 mM EDTA, containing
14 mM 2-ME. Free cysteines in the GST moiety were blocked by
treatment with 20 mM iodoacetamide for 1 h at room temperature
and then dialysed against 4 litres of 20 mM Tris/HCl, pH 8.0,
50 mM NaCl and 4 mM EDTA, followed by dialysis against
2×4 litres of refolding buffer (50 mM Tris/HCl, pH 8.5, 50 mM
NaCl and 10 mM CaCl2).
For GST-free RAP used in binding assays, a TEV cleavage site
was introduced between the GST and RAP moieties. GST-free
RAP was prepared by removing the N-terminal GST-tag with
TEVprotease after the GSH–Sepharose step. This was performed
in the presence of TEV protease (1:10000) during an overnight
dialysis at 4◦C against 4 litres of 20 mM Tris/HCl, pH 8.0,
50 mM NaCl and 4 mM EDTA supplemented with 14 mM 2-ME,
after the initial GSH–Sepharose step. The mixture was then
reapplied to the GSH column and GST-free RAP was collected
in the ﬂow-through. Pooled RAP was then dialysed against
2×1 litre of 50 mM sodium acetate, pH 5.0, and 50 mM NaCl
at room temperature, and subjected to a ﬁnal SP (sulfopropyl)-
Sepharose step eluting pure RAP with a 50–750 mM NaCl
gradient. The ﬁnal RAP sample, with a purity greater than 95%
as veriﬁed by SDS/PAGE, was prepared by dialysis into the assay
buffer(20 mMTris/HCl,pH 7.4,150 mMNaCland1 mMCaCl2).
Expression and puriﬁcation of RAP domains
RAP domains 1, 2 and 3 (see Supplementary Table S1) were
cloned in pQE30, modiﬁed to contain a TEV cleavage site, and
expressed in SG13009 cells. Cells were grown at 25◦Ci n2 Y T
media to D600 =0.6–1.0 before induction with 1 mM IPTG, and
harvested after 5 h. The protein was puriﬁed from cleared cell
lysatebynickelafﬁnitychromatography.TheN-terminalHis6-tag
wasremovedbyTEVcleavageandthesamplewasreappliedtothe
nickel afﬁnity column, collecting tag-free RAP domains in
the ﬂow-through. If further puriﬁcation was needed, a size-
exclusion chromatography step on a Superdex 75 column was
used. Final sample purity of more than 95% was veriﬁed by
SDS/PAGE.
Puriﬁcation of RAP-CR56 and RAP-CR345 complexes
RAP was mixed with a 4.8 molar excess of CR56 or CR345 and
applied directly to a 200 ml Superdex 75 size-exclusion column
equilibrated in 20 mM Tris/HCl, pH 7.4, 150 mM NaCl and
1m MC a C l 2. Fractions eluted at about 70 ml, corresponding to a
molecular mass higher than RAP alone, contained the complex.
The amount of protein applied to the column was based on two
criteria: ﬁrst, to ensure saturation of the complex, by keeping the
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concentration of each component well above 3 μM; secondly, to
maketheﬁnalabsorbanceat280 nmindirectlycollectedfractions
suitable for analytical ultracentrifugation analysis without further
concentration.
An estimate of the stoichiometry of the complex was obtained
by integrating the absorbance at 280 nm of the elution proﬁle
and using the individual extinction coefﬁcients, the initial molar
ratio of proteins, and the assumptions that all RAP is complexed
and that the late-eluting peak contained only CR protein. Both
assumptions were veriﬁed by SDS/PAGE.
Fluorescence spectroscopy
Bothﬂuorescenceemissionspectraandbindingexperimentswere
performed on a PTI Quantamaster spectroﬂuorimeter, equipped
with double monochromators on both the excitation and emission
sides. All experiments were performed in a quartz cuvette
in 1200 μl of 20 mM Tris/HCl, pH 7.4, 150 mM NaCl and
1m MC a C l 2 supplemented with 0.1% (w/v) PEG [poly(ethylene
glycol)] of 8000. The temperature of cuvette and sample was
controlled by a water bath set to 22◦C except for the 37◦C
experiments. For the low pH experiments, Tris was replaced by
20 mM Mes adjusted to pH 5.5.
Fluorescence spectra were recorded with an excitation wave-
length of 295 nm, scanning the emission wavelength region of
300–450 nm in 4 nm steps. As all proteins examined contain
tryptophan, the reference spectra of the individual components
were recorded and subtracted from complex spectra to obtain
the difference perturbation spectrum for the binding of each CR.
Protein concentrations of 100–2000 nM were used.
Binding experiments with RAP domains 1, 2 and 3 to (CR)x
species were performed with a ﬁxed amount of CR of between
100 and 4000 nM depending on the afﬁnity. Additions of 2 μlu p
to 40–60 μl of ligand were made to a ﬁnal ratio of ∼3.5:1 (350–
12500 nM). The ﬂuorescence change at 338 nm was measured
for an average of 60 s at each titration step, and the subsequent
titration curve was corrected for ligand without CR. It should
be noted that, although the ﬂuorescence perturbation may come
from either or both component, this is not relevant to the use of
theperturbationtofollowthebindingprocess.Theresultingcurve
was then ﬁtted to a standard 1:1 binding isotherm with ﬂoating
Fmax, Kd and CR concentration by non-linear least-squares ﬁt.
The ﬁtted CR concentrations provided an independent estimate
oftheindividualCRfoldingefﬁciencies,whichweretypically50–
100%. For binding experiments at pH 5.5 and 37◦C, the titration
was reversed, with CR56 titrated into RAP. This was done to
accommodate pH or temperature effects on the activity of the
RAP domains.
Todeterminethestoichiometryofcomplexformationwithfull-
length RAP, a ﬁxed concentration of RAP (100–1000 nM) was
titrated with (CR)x species up to 3.5 μMa n dt h ed a t aﬁ t t e dt o
various possible binding ratios of (CR)x species to RAP.
Analytical ultracentrifugation
All sedimentation velocity experiments were performed in a
Beckman XL-I analytical ultracentrifuge. Samples were exten-
sively dialysed into buffer (20 mM Tris/HCl, pH 7.4, 150 mM
NaCl and 1 mM CaCl2) and loaded into a dual sector charcoal-
ﬁlled Epon centrepiece. The samples were centrifuged at
50000 rev./min in an An60-Ti rotor and sedimentation was
monitoredbyabsorbanceat280 nm.Datawereanalysedusingthe
program SEDFIT, which generates a continuous c(s) distribution
for the sedimenting species [17]. Solvent densities and viscosities
were calculated with SEDNTERP [17].
For multisignal analysis of protein complexes, sedimentation
was followed measuring two signals from the proteins
simultaneously. Data were acquired using laser interferometry
and absorbance spectrophotometry at a wavelength of 280 nm.
Data were analysed according to the multisignal ck(s) method
implemented in the program SEDPHAT [18]. Brieﬂy, the
extinction coefﬁcients of the individual proteins were predeter-
mined in separate experiments with each protein component
alone. Global modelling of data acquired at the different
signals permits spectral distinction of the different sedimenting
protein components and allows for separate deconvolution of the
sedimentationcoefﬁcientdistributionsck(s)ofspeciescontaining
protein component k. Integration of a ck(s) peak yields the
concentration of a given component in that peak and comparison
of the two concentrations yields the stoichiometry of the proteins
in that peak.
ITC
Binding studies were performed on a MicroCal VP isothermal
titrational calorimeterat25 ◦C.Allprotein samplesweredialysed
intothesamebuffercontaining20 mMTris/HCl,pH 7.4,150 mM
NaCl and 1 mM CaCl2. CR56, diluted in dialysis buffer, was
titrated with 7–12 μl additions of D1, D2 or D3 at 25–55 μM.
Experiments with full-length RAP were performed with 3 μM
RAP in the cell, titrated with 7 μl injections of 45 μM CR56.
Injection peaks were integrated using Origin software provided
by the manufacturer. Integrated and progressively-summed heats
were used to follow binding progress. Data were ﬁtted by non-
linear least-squares analysis to a one binding-site model for
the single RAP domains, and a two independent site model
for intact RAP, using the program Scientist (MicroMath).
Control experiments of titrant into buffer were performed for
all titrants.
SDS/PAGE and non-denaturing PAGE
SDS/PAGE was performed using Novex 10–20% gels
(Invitrogen) with standard Laemmli buffers with or without
reducing agent (2-ME) in the loading buffer. Non-denaturing
PAGE was performed using Novex 8% gels, pre-run for 3.5 h at
15mAin375 mMTris/HCl,pH 8.8,and5 mMCaCl2 tointroduce
calcium into the gel. Gels were run in a standard Tris-glycine
buffer system, supplemented with 5 mM CaCl2 at 15 mA for
2.5 h. For gel-shift experiments, a ﬁxed amount of RAP or RAP
fragments was incubated with the indicated molar ratio of CR for
10 min at room temperature prior to loading.
RESULTS
Domain D3 binds tightly to all (CR)2 species
It has previously been shown qualitatively that all of the two
domain constructs from cluster II of LRP, except CR9 and CR10,
can bind with similar afﬁnity to domain D3 from RAP when they
are expressed as fusion proteins with ubiquitin [19]. Quantitative
SPR (surface plasmon resonance) and calorimetric data from
the same laboratory on the binding of D3 to the single tandem
construct ubiquitin–CR56 gave an afﬁnity of approx. 170 nM
[14]. We have now determined the afﬁnities of tandem pairs from
CR34 to CR89, expressed as non-conjugated species, for RAP
D3, using perturbation of tryptophan ﬂuorescence (Figure 1).
This has the advantage over previous studies that there are
no possible complications from attached tags or from steric
constraints imposed by surface immobilization. In keeping with
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Figure 1 Fluorescence determination of afﬁnities of CR fragments for RAP D3
Examples of emission spectra and ﬂuorescence determination of afﬁnities of CR fragments for RAP and its fragments. (A) Emission spectra of intrinsic tryptophan ﬂuorescence excited at 295nm of
() 200nM CR45, () 200nM RAP-D3, () mixture, () difference between mixture and RAP-D3 and () CR45 bound–unbound difference spectrum. (B) Change in tryptophan ﬂuorescence
followed at 338nm for 200nM CR45 titrated with 0–350nM RAP-D3, and corrected for D3 ﬂuorescence. Normalized raw data (n=3) are shown, with a best ﬁt to a 1:1 binding model.
Table 1 Afﬁnities of (CR)2 and (CR)3 species for RAP fragments D1, D2, and D3
D1 D2 D3
CR species Kd (nM)  G0 (kJ·mol−1) Kd (nM)  G0 (kJ·mol−1) Kd (nM)  G0 (kJ·mol−1)
CR34 38+ −11 −41.9+ −0.7 19+ −12 −43.6+ −1.8 3.5+ −0.4 −47.7+ −0.3
CR45 24+ −6 −43.0+ −0.6 30+ −11 −42.4+ −0.9 17+ −3 −43.8+ −0.4
CR56 20+ −3 −43.4+ −0.4 54+ −15 −41.0+ −0.7 37+ −3 −41.9+ −0.2
CR78 927+ −254 −34.0+ −0.7 116+ −68 −39.1+ −1.6 55+ −20 −41.0+ −0.9
CR89 35+ −6 −42.1+ −0.4 42+ −17 −41.6+ −0.5 20+ −5 −43.4+ −0.6
CR345 23+ −2 −43.1+ −0.2 23+ −2 −43.1+ −0.2 7+ −3 −46.0+ −1.1
CR456 6+ −1 −46.4+ −0.4 6+ −2 −46.4+ −0.8 8+ −1 −45.7+ −0.3
CR567 15+ −2 −44.1+ −0.3 18+ −5 −43.7+ −0.7 5.3+ −0.8 −46.7+ −0.4
CR678 859+ −518 −34.2+ −1.6 44+ −16 −41.5+ −0.9 26+ −10 −42.8+ −1.0
the qualitative ﬁndings of Andersen et al. [19], all of these pairs
couldbindtoD3(Table1).However,whereastheKd ofubiquitin–
CR56 to D3 was reported to be 170–700 nM [14], we now ﬁnd
a value 5–19-fold tighter (Kd =37 nM) for tag-free CR56, and
Kd values for the other tandem domains that range from 55 nM
for CR78 to as tight as 3.5 nM for CR34. Unlike the previously
reportedafﬁnities,thesearesimilarinmagnitudetothosereported
for binding of D3 to intact LRP [20].
Two CR domains provide most of the binding energy to D3
TheonlyX-raystructureofCRdomainsboundtoanypartofRAP
is of two CR domains from LDLR bound to RAP D3 [21]. In this
structure,thetwoCRdomainslieatanacuteangletothelongaxis
of the elongated D3, but span less than two-thirds of the length of
D3. Thus there is space on the surface of D3 for an additional CR
domain to bind. We therefore examined whether (CR)3 species
might bind with a signiﬁcantly higher afﬁnity than (CR)2
species to D3. Although most of the (CR)3 species examined
had increased afﬁnity to D3, with Kd values reduced to single
digit nanomolar values, the increase represented only a 3–11%
increase in binding energy (Table 1). The only exception was
CR678, which bound with a Kd of 26 nM. Thus most of the
binding energy of binding to D3 arises from interactions with
two CR domains, and presumably mimics the interactions seen
in the X-ray structure of D3 with LA34 (where LA3 and LA4 are
the third and fourth CR domains from the ligand-binding cluster
of LDLR) [21].
Domains D1 and D2 can also bind to LRP fragments with very high
afﬁnity
A previous study that examined the binding of D1 or D2 to
fragments of LRP concluded that the afﬁnities are low, with
Kd of 2.8 μM and 19 μM respectively to ubiquitin-conjugated
CR56 [14]. Given the much higher afﬁnities that we found for
D3 binding to LRP fragments than found by others, we wanted
to repeat binding experiments on D1 and D2, but using the whole
rangeoftwoandthreedomainspecieswehadusedforD3binding.
Somewhat surprisingly we found that, at least to fragments that
did not contain both CR7 and CR8 domains together, binding was
as tight or even tighter than to D3 (Table 1). The tightness of
binding is also seen in gel-shift assays, where both D1 and D2
give clear shifts that are saturable (Figure 2). Even for the two-
domain constructs, Kd values were in the 19–54 nM range and
tightened to 6–18 nM for three domain constructs. Only binding
thatinvolvedCR78,eitheraloneorinthelongerconstructCR678,
wassigniﬁcantlyweaker,withKd valuesof44–930 nM.However,
even these are much tighter than reported elsewhere for either of
these RAP domains [14]. Together with the results on binding
of D3, this implies that there might be three tight binding sites in
RAP for two or three domain fragments of LRP.
Inﬂuence of temperature on binding
Ithasbeensuggestedthattheprincipalmechanismofdissociation
of ligands from RAP D3 depends on promoting the unfolding of
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Figure 2 Gel-shift assay of binding of D1, D2 and D3 to CR56
Binding of CR56 to RAP-D1, D2, and D3 by non-denaturing gel-shift assay. The Figure shows
themigrationof2μgoftheindicatedRAP-domain(D1,D2orD3)incubatedwith0,1or2molar
ratio of CR56 on an 8% non-denaturing PAGE. The migration of 3 μg of CR56 alone is shown
in the far-right lane.
this domain by ionization of histidines as the pH is lowered upon
movement of LRP–RAP from the ER to the Golgi [22,23]. Since
it has marginal stability at physiological temperature (Tm∼42◦C)
[10], one might expect that such a destabilization mechanism
would also be apparent at constant pH upon increasing the tem-
perature. We therefore examined the effect of increasing the
temperature from 22◦Ct o3 7◦C at pH 7.4 on the binding of CR56
(which binds tightly to all three RAP domains at 22◦C) to D1, D2
and D3. Surprisingly, only the most stable domain, D1, showed a
reduction in afﬁnity, and then by less than a factor of 2, whereas
D2 and the least stable D3 actually increased their afﬁnity 2- and
5-fold respectively (Table 2).
Effect of pH on binding to CR56
The effect of lowering the pH from 7.4 to 5.5 was examined at
37◦C for binding of CR56 to each of the three RAP domains.
Both D2 and D3 showed a reduction in afﬁnity, though this was
only 2-fold for D2 and 6-fold for D3 (Table 2). In contrast, the
afﬁnityofD1wasunaffected.Althoughthissuggeststhathistidine
ionization might destabilize D3, the effect is not large, resulting
in only a 10% reduction in free the energy of binding.
Intact RAP possesses only two high-afﬁnity sites for LRP fragments
GiventhateachofD1,D2andD3canbindtightlytomosttandem
andtripleCRfragmentsfromclusterIIofLRP,wenextexamined
how many such CR fragments could bind to intact RAP. This was
examined in several ways. First, we examined binding by gel-
shift assay. Both (CR)2 and (CR)3 species gave clear shifts in
the position of RAP that seemed to saturate at approximately two
equivalents(Figure3).Thesecondapproachwasmorequalitative
Figure 3 Gel-shift assay of binding of CRx to intact RAP
Binding titration of CR56, CR345 and CR456 to RAP by non-denaturing gel-shift assay. The
Figure show the migration of 2.5 μg of RAP either alone (RAP) or incubated with the indicated
molar ratios of CR by 8% non-denaturing PAGE. (A) RAP incubated with 1–7 molar ratios of
CR56. (B) RAP incubated with 1–8 molar ratios of CR345. (C) RAP incubated with 1–8 molar
ratios of CR456. The migration of 7μg of the indicated CR alone is shown in the far-left lane of
each respective gel.
and used titration of CR species into RAP followed using the
same ﬂuorescenceperturbation techniqueasusedfor determining
individualafﬁnitiesabove.BindingofCR456(Figure4)orCR345
toRAPresultedinsaturablebinding,whichcouldbewellﬁttedto
twotightbindingsites(Table3).CR56alsogavesaturablebinding
that could be ﬁtted to two tight binding sites (Table 3). Given that
both binding sites appear to be quite tight it is difﬁcult to obtain
accurate values for both Kd values simultaneously. However,
ﬁxing one Kd at the value for binding of the CR fragment to
D1 gave the second, weaker Kd in the range 36–56 nM, indicating
that the presence of the ﬁrst fragment did not antagonize binding
of the second in a major way. Finally, we puriﬁed complexes
Table 2 Temperature and pH dependence of afﬁnities of D1, D2 and D3 for CR56
D1 D2 D3
Temperature (◦C) pH Kd (nM)  G0 (kJ·mol−1) Kd (nM)  G0 (kJ·mol−1) Kd (nM)  G0 (kJ·mol−1)
22 7.4 20+ −3 −43.4+ −0.4 54+ −15 −41.0+ −0.7 37+ −3 −41.9+ −0.2
37 7.4 29+ −7 −44.6+ −0.6 22+ −11 −45.3+ −1.4 7+ −2 −48.3+ −0.8
37 5.5 26+ −11 −44.9+ −1.2 46+ −9 −43.4+ −0.5 41+ −11 −43.7+ −0.7
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Figure 4 Fluorescence titration of CR into RAP
Change in intrinsic tryptophan ﬂuorescence followed at 338nm. (A) RAP (100nM) titrated with 0–500nM CR56 and (B)1μM RAP titrated with 0–2.7μM CR456. Normalized raw data with a best
ﬁt to a two-binding site model is shown.
Table 3 Afﬁnities of binding sites in intact RAP for (CR)2 and (CR)3
fragments
Kd1
∗ (nM) Kd2 (nM)
CR56 20 56+ −8
CR345 20 42+ −11
CR456 10 36+ −5
∗ The ﬁt to two tight binding sites was made by ﬁxing the ﬁrst Kd at a value close to that
found for binding of the same fragment to D1 alone.
of RAP with both CR56 and CR345, by adding excess CR56
or CR345 to RAP and fractionating by size, and then examined
their properties by sedimentation velocity measurements. Size-
exclusion chromatography gave clear separation of complex
from unbound (CR)x fragments (Figure 5). A stoichiometry
of 1:2.1 (RAP:CR56) and 1:1.8 (RAP:CR345) was estimated
by integrating the elution proﬁles. Sedimentation velocity gave
sedimentation coefﬁcients (s20,w) for the complexes of 3.79 and
4.26 compared with 2.7 for RAP alone (Table 4 and Figure 6).
Bestﬁtstothedatagavemolecularmassesof53 kDafortheRAP–
CR56complex,66 kDafortheRAP–CR345complexand38 kDa
for RAP alone. These are consistent with the larger species being
2:1 complexes of either CR56 (8.9 kDa) or CR345 (13.6 kDa)
with RAP (38 kDa). This stoichiometry is also supported by
multisignal analysis of the sedimentation velocity data, which
independentlygivesratiosforthecomplexesof1:2.6(RAP:CR56)
and 1:2.3 (RAP:CR345) (see insets of Figure 6). The frictional
ratiosof1.47forRAP,1.38fortheRAP–CR56complex,and1.38
for the RAP–CR345 complex are consistent with an elongated
shapeforeachspecies,thoughwithanincreaseinthethicknessof
thecomplexes,presumablyreﬂectingtheassociationoftwoCR56
or CR345 fragments along the long axis of the RAP molecule.
ITC analysis of binding of CR56
Although our ﬂuorescence approach to measuring Kd values
for the various RAP–CR interactions has an advantage over
ITC of being able to be carried out at much lower protein
concentrations and is therefore better for accurate determination
of tight interactions, we nevertheless wanted some independent
quantitativecorroborationofourprincipalﬁndingsthat(i)D1,D2
and D3 could each bind tightly to CR fragments, and (ii) that only
twohigh-afﬁnitybindingsitesarepresentinintactRAP.Wechose
Figure 5 Size-exclusion chromatographic separation of (CR)x–RAP
complexes
Puriﬁcation of RAP–CR56 and RAP–CR345 complexes by size-exclusion chromatography. The
proﬁles show the separation of RAP-CR56 () and RAP-CR345 () complexes from 1:4.8
RAP:CR mixtures. As conﬁrmed by SDS/PAGE (results not shown), RAP–CR complexes elute
closeto70 ml,whereasun-complexedCR56andCR345eluteat112mland98mlrespectively.
RAP alone in an equivalent amount is shown as a solid line.
Table 4 Analytical ultracentrifugation of RAP, CR56, CR345 and their
complexes
Species Mr (kDa)∗ Mr (kDa)† sw,20
‡ f/f0§ a/b¶
RAP 38+ −2 37.8 2.7+ −0.1 1.47+ −0.02 6.9+ −0.3
CR56 7.8+ −0.3 8.9 1.49+ −0.02 1.46+ −0.04 5.5+ −0.5
RAP–(CR56)2 53+ −3 55.6 3.79+ −0.02 1.38+ −0.04 4.7+ −0.6
CR345 14.2+ −0.1 13.6 1.87+ −0.01 1.37+ −0.01 4.4+ −0.1
RAP–(CR345)2 66+ −36 5 4 . 2 6 + −0.01 1.38+ −0.05 4.8+ −0.7
∗ Molecular mass calculated from sedimentation data.
† Molecular mass calculated from sequence and stoichiometry of 1:2 for RAP:(CR)x
complexes.
‡ Temperature-corrected sedimentation coefﬁcient at 20◦Ci nw a t e r .
§ Frictional ratio.
¶Shape factor expressed as ratio of long to short axes (a/b) for a prolate ellipsoid.
to examine the binding of CR56, since this is the LRP fragment
for which ITC data exist for binding to RAP, albeit for ubiquitin-
conjugated CR56 [14,15]. Using a low μM concentration of
CR56. we found that D1, D2 and D3 could all bind quite tightly
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Figure 6 Sedimentation velocity analysis of (CR)x–RAP complexes
Analysis of RAP–CR56 and RAP–CR345 complexes by analytical ultracentrifugation. Overlay of sedimentation velocity proﬁles for CR (thin line), RAP(thick line), and puriﬁed RAP–CR complex ()
are shown. (A) CR56. (B) CR345. The respective global ﬁts for extinction coefﬁcient-based stoichiometry determination are shown as small insets in top right corner of (A and B) [CR (thin line),
RAP (thick line)].
Figure 7 ITC analysis of binding of CR56 to RAP and RAP fragments
(A) Titration of D1 into 1.8 μM CR56; (B) titration of D2 into 4.6 μM CR56; (C) titration of D3 into 1.8 μM CR56; (D) titration of CR56 into 3 μM RAP. The upper part of each panel gives the raw
ITC data for the titration prior to correction for dilution of titrant, and the lower portion gives the best ﬁt of the data to a single site model (A–C) or a two-site model (D).
(Figures 7A–7C). The Kd values obtained were 62 nM, 270 nM
and 77 nM respectively. Although these are somewhat weaker
than found above by ﬂuorescence (20 nM, 54 nM and 37 nM),
they clearly demonstrate tight binding of all three isolated RAP
domains to CR56 that has no attached protein tag. The somewhat
lower afﬁnities obtained by ITC probably reﬂect the need to
use higher protein concentration and the signiﬁcant correction
to the raw heat data that must always be made for the control
titration of titrant into buffer. Our ITC values, however, stand in
marked contrast to those reported previously for ubiquitin–CR56
binding to the same RAP fragments. Thus for D1, our value
of 62 nM compares with a reported value of 2650 nM, for D2
270 nM compares with 16700 nM and for D3 77 nM compares
with 126 nM.
We also examined binding of CR56 to intact RAP and found
binding that corresponded to a stoichiometry of two CR56 to
one RAP (Figure 7D), further supporting the ﬂuorescence, gel-
shift, size-exclusion chromatography and sedimentation velocity
analyses reported above. One beneﬁt of the ITC analysis was
that it also provided  H values for all binding processes. These
were −77.0 kJ·mol
− 1, −36.8 kJ·mol
− 1 and −71.6 kJ·mol
− 1
respectively for D1, D2 and D3, and the overall  H for binding
of two equivalents of CR56 to intact RAP was −164.1 kJ·mol
− 1,
whichismoreconsistentwithbindingofCR56toD1andD3than
with binding to D2 and either D1 or D3.
DISCUSSION
By ﬂuorescence, gel-shift assay, ITC, analytical ultracentrifuga-
tion and size-exclusion chromatography, we have demonstrated
that all three RAP domains bind tightly to nearly all fragments
from LRP cluster II. Kd values were in the low to mid nM range.
This contrasts with an earlier study that found extremely weak
binding (μM) for D1 and D2, and binding for D3 that, though
tighter, was orders of magnitude weaker than for D3 to intact
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LRP [14]. This high afﬁnity but low speciﬁcity is not surprising
giventhechaperonefunctionofRAPandthemodeofbindingseen
in the D3–LA34 complex [21], which involves co-ordination of
an exposed lysine by the calcium-binding region that is common
to all CR domains [24–27]. The source of the disagreement is
unclear, but may result from use of ubiquitin-conjugated CR
fragments, immobilization of ligands, use of CR domains from
LDLR, for which RAP is not thought to be the in vivo chaperone
[23],ortheloweraccuracyofITCformeasuringtightinteractions
when very high protein concentrations are used.
Fortheﬁrsttime,bindingdatafor(CR)3 fragmentsarereported.
These show that a third CR domain contributes very much less to
binding than the average contribution of each of the ﬁrst two do-
mains. This suggests that, although there are likely to be two ‘hot
spot’ lysines on each of D1, D2 and D3, each of which engages
with a CR domain via its calcium-binding region, there is no third
such interaction. Importantly, we have shown that only two of
the three binding sites are available in intact RAP, though they
retain the very high afﬁnities seen for isolated RAP domains to
the respective (CR)x species. This is in agreement with a study
that identiﬁed one high-afﬁnity binding site in the N-terminal half
of RAP and one in the C-terminal half [13]. It is also in keeping
with an earlier study from this laboratory that found two binding
sites for CR78 to intact RAP [28]. With the beneﬁt of hindsight, it
was unfortunate that we chose CR78, since this is the ‘odd-man-
out’ in having relatively low afﬁnity for D1 and D2. Nevertheless,
the conclusion reached there of two binding sites is the same as
reached here with a more extensive range of much tighter binding
species.
Based on the existence of two high-afﬁnity binding sites, on
a model for RAP derived from NMR structures of each of the
three RAP domains [28a], and on two structures of RAP domain
complexes with (CR)2 fragments, one from X-ray [21] and one
from NMR and modelling [15], we propose a model for the
binding of RAP to a contiguous stretch of CR domains. In this
model the locations of the two (CR)2 fragments from the struc-
turesofD1andD3inseparatecomplexeshavebeensuperimposed
ononeoftheensembleof20energy-minimizedstructuresofRAP
(Figure 8). Model 2 was chosen as being one with lowest energy
and one that best ﬁtted the elongated structure of RAP implied
by the high frictional ratio obtained here from sedimentation
velocity data. The orientation of D3 relative to D1 would allow
a contiguous stretch of CR domains to bind in the same manner
as in the two complexes of isolated domains. It is intriguing that,
when two (CR)2 fragments are positioned in this way, there is
just sufﬁcient space between their C and N-terminal ends to
accommodateanadditionalpairofdomains,althoughinalocation
that does not give direct additional contact with the globular parts
of either D1 or D3. This could explain how two (CR)3 fragments
bind to intact RAP with only slightly higher afﬁnity than two
(CR)2 fragments. A ﬁnal pleasing aspect of the model is that
D2 is approximately orthogonal to the long axis that runs along
D1 and D3. If the binding site on D2 for a (CR)2 fragment is
parallel to the long axis of the domain, as it is in D1 and D3, it
might not be possible to simultaneously engage all three binding
sites in intact RAP without interference. This would explain the
stoichiometry of 2:1 rather than 3:1 for (CR)x binding to intact
RAP. Furthermore, the  H values obtained for binding CR56 to
intact RAP compared with isolated domains favour binding to D1
a n dD 3i ni n t a c tR A Pr a t h e rt h a nt oD 2i nc o m b i n a t i o nw i t h
either D1 or D3. Although our binding experiments using a single
typeof(CR)x speciesprecludedbeingabletosimultaneouslybind
different fragments of cluster II to RAP, it is clear from Table 1
that RAP could tightly engage CR3–CR8, with D1 binding to
CR345 (Kd of 23 nM) and D3 binding to CR678 (Kd of 26 nM).
Figure 8 Model of RAP–cluster II complex
ModelofRAPbindingtoCRstretches.TheLowenergysolution2fromaRAPstructuremodelling
study by Lee et al. [28a], using individual NMR structures of RAP domain 1, 2 and 3 (PDB ID
2P01), is shown in a grey ribbon diagram. D1 is aligned with the D1 from a D1-CR56 complex
based on NMR data by Jensen et al. [15] (PDB ID 2FYL). D3 is aligned with D3 from the
X-ray crystal structure of D3 in complex with LA34 from the LDLR by Fisher et al. [21] (PDB
ID 2FCW). CR5 and CR6 are shown in red and blue space-ﬁll respectively. LA3 and LA4 are
shown in yellow and green space-ﬁll respectively. N- and C-termini of the CR and LA tandem
repeatsandtheidentityoftheRAPdomainsareindicated.Topandbottomstructuresarerelated
by a 90◦ rotation around a horizontal axis through the middle of the Figure. An outline trace
of the CR56 space-ﬁlling structure in the bottom structure has been positioned between the
end of the tandem domain bound to D1 and the tandem domain bound to D3 (shown in red
dashes), to represent a possible location of an additional CR tandem repeat. The numbering
CR3 through CR8 below the CR domains in the bottom representation indicates how the (CR)6
species CR3–CR8 might bind.
Thepresenceoftwosuchhigh-afﬁnitybindingsiteswithinRAP
shouldhaveprofoundconsequencesforthechaperonefunctionof
RAP. A landmark study showed that a receptor–ligand complex
between a synthetic trivalent vancomycin and a trivalent D-Ala-
D-Ala ligand had binding energy that was approximately equal to
the sum of the three separate binding energies of the monovalent
ligand and receptor [29], resulting in an astonishing 40 aM
(4×10
− 17 M)Kd forthetrivalentsystem.Moreintriguingly,since
a monovalent ligand could compete for any of the individual
interactions in the trivalent complex, the dissociation kinetics
of the trivalent complex using a monovalent competitive ligand
reﬂected the off rate for the individual interactions rather than
the much slower dissociation of the whole trimer. This system
thus combined ultra high afﬁnity with the ability to compete off
parts of the whole ligand at relatively fast rates [30]. This has
previously been exploited in the design of retractable, but high
afﬁnity, bivalent inhibitors of thrombin [31].
The consequences for RAP–LRP are two-fold. The ﬁrst is that,
with two binding sites on RAP for up to 3 CR domains each, with
individual Kd value of ∼25 nM, RAP should bind to cluster II
with an overall Kd of ∼0.6 fM. The second is that, even though
theoverallafﬁnityofRAPforclusterIIshouldbeultra-high,each
of the two binding sites should be displaceable by a ligand with
afﬁnityequalonlytothatoftheindividualsite.Thiscouldexplain
the apparent conﬂict between the present proposal for ultra-high-
afﬁnity binding of RAP to LRP and the many literature reports of
binding of RAP to LRP only in the low-nanomolar range, since
most such binding studies infer an afﬁnity by competition with a
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ligand (whether bivalent RAP or monovalent D3) that could bind
at either of the two sites on RAP that is bound to LRP. Such ultra-
high afﬁnity of RAP for folded cluster II would facilitate its func-
tionasafoldingchaperone,whilestillallowingrapiddissociation
in two steps by competition with ligands that separately target
each of the two binding sites on RAP. An obvious candidate for
such a competing ligand are the YWTD ‘propeller’ domains that
ﬂank the ligand-binding clusters in LRP and other LDLR family
members[32].LRPhaseightYWTDdomains,withfourﬂanking
cluster II. In a beautiful structure of the extracellular portion of
LDLR at low pH, it was shown that the single YWTD domain
present interacted with CR modules 4 and 5 of the lipoprotein-
binding region [33]. It was proposed that several histidines at the
interface between the YWTD domain and the CR domains might
promote binding of YWTD to CR at low pH and thereby displace
lipoprotein bound at, or close to, that same site. In support of this,
it was recently shown that displacement of bound lipoprotein
depends on these histidines in the YWTD domain in the expected
pH-dependentmanner[34].Byextension,displacementofRAPat
thepHoftheGolgimightoccurbyasimilarmechanism.Themain
difference is that, since RAP has two tight binding sites on cluster
II, two such YWTD domains would be needed, one for each
binding site. However, there are quite sufﬁcient YWTD domains
available, ﬂanking each end of the cluster. YWTD modules could
then effectively displace a single RAP, even though the latter
bound with overall ultra-high afﬁnity, by individually displacing
each of the two binding sites on RAP.
This proposal for the basis of pH-dependent release of RAP
from LRP is at variance with previous studies that suggested
that pH-dependent unfolding of RAP D3, resulting from histidine
protonation, is the cause of RAP dissociation [22,23]. There
are, however, a number of concerns with these studies. One is
that, even if D3 dissociated in this manner, D1 should remain
tightly bound, based on the pH-independence of the high-afﬁnity
interaction of D1 with CR56 found here. The second is that,
althoughwealsofoundthatlowerpHreducestheafﬁnityofCR56
for D3, the reduction is small (from 7 nM at pH 7.4 to 41 nM at
pH 5.5). Indeed, in previous competition studies between wild-
type D3 and D3 with mutated histidines, a similar relatively small
reduction in afﬁnity (∼7–9 fold) was found [22]. A ﬁnal concern
that applies to cell-based studies on LRP ‘mini-receptors’ is that,
tothebestofourunderstanding,noneofthesetruncatedreceptors
containsanyYWTDdomains[6,22,35].Ifthesedomainsdoplaya
dominant role in RAP release, andhence in trafﬁcking of receptor
to the cell surface, the results obtained could be misleading, by
focusing on a second-rank event such as modest weakening of D3
afﬁnity, rather than the principal player.
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SUPPLEMENTARY ONLINE DATA
Receptor-associated protein (RAP) has two high-afﬁnity binding sites for the
low-density lipoprotein receptor-related protein (LRP): consequences for
the chaperone functions of RAP
Jan K. JENSEN, Klavs DOLMER, Christine SCHAR and Peter G. W. GETTINS1
Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 S. Ashland, M/C 669, Chicago, IL 60607, U.S.A.
Table S1 Fragments of LRP and RAP used in the present study
Construct Residues
CR34 Gln833∗–Tyr914
CR45 His874–Tyr954
CR56 Arg915–His994
CR78 His994–Gly1080
CR89 Gly1041–Ser1123
CR345 Gln833–Tyr954
CR456 His874–His994
CR567 Arg915–Asn1034
CR678 Pro955–Gly1080
RAP D1 Tyr1–Leu112
RAP D2 Asp113–Glu215
RAP D3 Arg206–Leu323
*The residue numbering corresponds to that of the mature protein. The expressed fragments
contain an additional N-terminal Gly-Ser extension resulting from the use of a BamHI site in
cloning.
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